Synthesis and structure-activity relationships of USP48 deubiquitinylase inhibitors

被引:1
|
作者
Boehm, Kevin [1 ,2 ]
Schulze-Niemand, Eric [1 ]
Kaehne, Thilo [1 ]
Siddiqui, Elisa [1 ]
Taeger, Christian [1 ]
Ramsbeck, Daniel [2 ]
Buchholz, Mirko [2 ]
Naumann, Michael [1 ,3 ,4 ]
机构
[1] Otto Guericke Univ, Inst Expt Internal Med, Magdeburg, Germany
[2] Fraunhofer Inst Cell Therapy & Immunol IZI, Dept Drug Design & Target Validat MWT, Bioctr, Halle, Germany
[3] Otto Guericke Univ, Inst Expt Internal Med, Med Fac, Leipziger Str 44, D-39120 Magdeburg, Germany
[4] PerioTrap Pharmaceut GmbH, Bioctr, Halle, Germany
关键词
chemical synthesis; drug design; papain-like protease; ubiquitin-specific proteases; USP2; SMALL-MOLECULE INHIBITOR; UBIQUITIN; SPECIFICITY; DISCOVERY; CELLS;
D O I
10.1002/ardp.202200661
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Ubiquitin-specific proteases represent a family of enzymes that catalyze the cleavage of ubiquitin from specific substrate proteins to regulate their activity. USP48 is a rarely studied USP, which has recently been linked to inflammatory signaling via regulation of the transcription factor nuclear factor kappa B. Nonetheless, a crystal structure of USP48 has not yet been resolved and potent inhibitors are not known. We screened a set of 14 commercially available USP inhibitors for their activity against USP48 and identified the USP2 inhibitor "ML364" as a candidate for further optimization. Using a ligand-based approach, we derived and synthesized a series of ML364 analogs. The IC50 concentrations of the new compounds to inhibit USP48 were determined in a deubiquitinylase activity assay by measuring the fluorescence intensity using tetra-ubiquitin rhodamine110 as substrate. A compound containing a carboxylic acid functionalization (17e) inhibited USP48 activity toward tetra-ubiquitin rhodamine110 with an IC50 of 12.6 mu M. Further structure-based refinements are required to improve the inhibition activity and specificity.
引用
收藏
页数:17
相关论文
共 50 条
  • [21] STRUCTURE-ACTIVITY RELATIONSHIPS IN ADENOSINE DEAMINASE INHIBITORS
    SCHAEFFE.HJ
    JOHNSON, RN
    ODIN, E
    HANSCH, C
    JOURNAL OF MEDICINAL CHEMISTRY, 1970, 13 (03) : 452 - &
  • [22] Structure-activity relationships in aminocyclopentitol glycosidase inhibitors
    Dickson, LG
    Leroy, E
    Reymond, JL
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2004, 2 (08) : 1217 - 1226
  • [23] Quantitative structure-activity relationships of dihydrofolatereductase inhibitors
    Zare-Shahabadi, Vahid
    MEDICINAL CHEMISTRY RESEARCH, 2016, 25 (12) : 2787 - 2797
  • [24] Quantitative structure-activity relationships of molting inhibitors
    Nakagawa, Y
    JOURNAL OF PESTICIDE SCIENCE, 1996, 21 (03) : 363 - 377
  • [25] Quantitative Structure-Activity Relationships of Renin Inhibitors
    Gupta, Satya P.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2003, 3 (04) : 315 - 321
  • [26] Corrosion inhibitors:: Quantitative structure-activity relationships
    Lukovits, I
    Shaban, A
    Kálmán, E
    RUSSIAN JOURNAL OF ELECTROCHEMISTRY, 2003, 39 (02) : 177 - 181
  • [27] Synthesis and structure-activity relationships of teixobactin
    Karas, John A.
    Chen, Fan
    Schneider-Futschik, Elena K.
    Kang, Zhisen
    Hussein, Maytham
    Swarbrick, James
    Hoyer, Daniel
    Giltrap, Andrew M.
    Payne, Richard J.
    Li, Jian
    Velkov, Tony
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2020, 1459 (01) : 86 - 105
  • [28] Synthesis, Structure-Activity Relationships and Biological Activity of New Isatin Derivatives as Tyrosinase Inhibitors
    Gencer, Nahit
    Sonmez, Fatih
    Demir, Dudu
    Arslan, Oktay
    Kucukislamoglu, Mustafa
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2014, 14 (12) : 1450 - 1462
  • [29] SYNTHESIS AND STRUCTURE-ACTIVITY RELATIONSHIPS OF BACTERIOCINS
    Vederas, J.
    BIOPOLYMERS, 2009, 92 (04) : 303 - 303
  • [30] Synthesis and structure-activity relationships of dehydroaltenusin derivatives as selective DNA polymerase α inhibitors
    Kuramochi, Kouji
    Fukudome, Keishi
    Kuriyama, Isoko
    Takeuchi, Toshifumi
    Sato, Yoshihiro
    Kamisuki, Shinji
    Tsubaki, Kazunori
    Sugawara, Fumio
    Yoshida, Hiromi
    Mizushina, Yoshiyuki
    BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (20) : 7227 - 7238